Limit Dose and Duration of NSAIDs in High-CV-Risk Patients

January 2017

Controversy will continue to brew over the safety of NSAIDs in patients at high cardiovascular risk.

All NSAIDs have a boxed warning about increased risk of CV events.

But the thinking has been that CV risk varies...with celecoxib (Celebrex, etc) more risky and naproxen the least risky.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote